Objective-The platelet glycoprotein Ib-IX (GP Ib-IX) receptor is a well-characterized adhesion receptor supporting hemostasis and thrombosis via interactions with von Willebrand factor. We examine the GP Ib-IX/von Willebrand factor axis in murine polymicrobial sepsis, as modeled by cecal ligation and puncture (CLP). Approach and Results-Genetic absence of the GP Ib-IX ligand, von Willebrand factor, prolongs survival after CLP, but absence of the receptor, GP Ib-IX, does not. Because absence of either von Willebrand factor or GP Ib-IX significantly impairs hemostasis and thrombosis, we sought to define additional GP Ib-IX-dependent pathways impacting survival in the CLP model. We document that the absence of GP Ib-IX leads to reduced platelet-neutrophil and platelet-monocyte interactions. Twenty-four hours after CLP, absence of GP Ib-IX coincides with an alteration in cytokine levels, such as tumor necrosis factor-α secreted by monocytes, and increased macrophage-1 antigen expression by neutrophils. Conclusions-In contrast to the well-characterized proinflammatory properties of platelets, we describe in the CLP model an anti-inflammatory property associated with platelet GP Ib-IX. Thus, a single platelet receptor displays a dual modulatory role in both the thrombotic and inflammatory pathways associated with polymicrobial sepsis. In sharing leucine-rich motifs with toll-like receptors, platelet GP Ib-IX can be considered a multifunctional participant in hemostasis, thrombosis, and the inflammatory cascade. The results highlight a dynamic role for platelets in systemic inflammation and add to the complex pathophysiologic events that occur during the dysregulated coagulation and inflammation associated with sepsis. 
T he well-established role of circulating blood platelets is to support hemostasis and thrombosis. Platelets constantly survey the vasculature and on recognition of vessel injury aggregate to form a platelet-rich hemostatic plug and limit blood loss. 1, 2 The ability of platelets to aggregate also contributes to cardiovascular diseases because the platelet-rich thrombus obstructs blood flow. 3, 4 More recently, platelet function beyond hemostasis and thrombosis is being recognized with relevance to disease pathways associated with inflammation and cancer. [5] [6] [7] Relative to inflammation, platelets affect a wide range of immune functions including leukocyte migration, release of proinflammatory mediators, release of antimicrobial proteins, promotion of neutrophil extracellular trap formation, and expression of toll-like receptors. [8] [9] [10] [11] [12] [13] Thus, platelets are an active extension of the immune system most likely reflecting the ancestral origins of the mammalian platelet to the thrombocyte of lower vertebrates. [14] [15] [16] [17] 
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Sepsis is a dynamic syndrome bridging several seemingly distinct pathophysiologic events, most notably inflammation and coagulation. 18 Indeed, the complexity of sepsis pathophysiology has made it one of the most difficult clinical conditions to model in animals. 19 However, given the complexity and potential inter-relationships of different pathways, animal models are indispensable and have been valuable to characterize the role of specific genes and pathophysiologic processes in the progression of the syndrome. 19 For the current study, we used mice deficient in platelet glycoprotein Ib-IX (GP Ib-IX) with well-characterized defects in hemostasis and thrombosis mimicking the human disorder, the Bernard-Soulier syndrome. 20, 21 These mice lack the platelet adhesion receptor for von Willebrand factor (VWF), an essential ligand for tethering platelets to damaged or altered endothelial surfaces. 22 Although the best characterized function of GP Ib-IX is binding to VWF, GP Ib-IX has a diverse array of other ligands. 23 One such ligand is the leukocyte integrin macrophage-1 antigen (Mac-1; CD11b/CD18), which plays an integral role in promoting the migration of immune cells into extravascular tissues. 24, 25 Although there have been limited data addressing the in vivo consequences of this interaction, it establishes a potential involvement for GP Ib-IX in the process of inflammation.
Using a model of GP Ib-IX dysfunction (human interleukin-4 receptor [hIL-4R]/Ibα), we present studies to determine the physiological consequence of platelet GP Ib-IX in a mouse model of dysregulated inflammation, the cecal ligation and puncture (CLP) model. 19, 26 Mice devoid of VWF have improved survival after CLP, whereas mice deficient in the VWF receptor, GP Ib-IX, do not have improved survival. We identify GP Ib-IX contributions to a platelet/neutrophil and platelet/monocyte axis with significant consequences to the innate immune response as evidenced by cytokine levels and increased Mac-1 expression. Our results illustrate a platelet interface between coagulation and inflammation involving the GP Ib-IX complex.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Platelet GP Ib-IX/VWF Axis in CLP
Previously, VWF knockout mice have been reported to have prolonged survival after a CLP surgery to induce severe sepsis. 27 Because VWF serves as the primary ligand for the platelet GP Ib-IX receptor, we hypothesized that the absence of the ligand binding subunit (GP Ibα) of the receptor would improve septic survival in a similar manner. The CLP procedure was performed on male cohorts of wild-type (WT; C57BL/6J), VWF knockout, and hIL-4R/Ibα mice ( Figure 1 ). Interestingly, survival of hIL-4R/Ibα mice after CLP was not statistically different from the WT group, whereas survival for VWF knockout mice was improved. Thus, eliminating the ligand portion of the GP Ib-IX/VWF axis improves survival in this model, whereas eliminating the receptor portion of the axis was not beneficial. Twenty-four hours after CLP, all strains displayed an ≈50% reduction in circulating platelet counts, typical of the consumptive coagulopathy associated with septic shock (not shown).
Platelet GP Ib-IX/Neutrophil and Monocyte Axes
The leukocyte integrin Mac-1 (CD11b/CD18) has been reported to be a counter-receptor for GP Ibα. 24, 25 To further understand the role of GP Ib-IX in potentially influencing outcome in murine CLP, we assessed whether disrupting GP Ib-IX altered the extent of platelet association with neutrophils and monocytes. Whole blood collected from WT, hIL-4R/Ibα, and VWF knockout mice was stained using a platelet-specific marker (CD41), a neutrophil/ granulocyte marker (Gr-1), and a monocyte/macrophage marker (CD115). The number of platelet-neutrophil/monocyte interactions was analyzed via flow cytometry. The surface marker Gr-1 is an indicator of granulocytes, with neutrophils being the most predominant granulocyte. Therefore, Gr-1 + staining is interpreted loosely as a marker for the neutrophil population. − events illustrates platelet-neutrophil interaction based on glycoprotein Ib-IX (GP Ib-IX) expression. WT and VWF KO express endogenous GP Ib-IX and are indiscernible from one another (P=0.54), but both exhibit significantly higher platelet-neutrophil levels compared with hIL-4R/Ibα (P<0.001). This establishes a GP Ib-IX role in augmenting platelet binding to neutrophils. C, Using CD115 + fluorescence to gate exclusively onto monocytes (lower right gray box in A), the GP Ib-IX-dependent association with platelets is presented. Comparison of the sample groups showed the WT and VWF KO strains to be indistinguishable (P=0.24). Blood from hIL-4R/Ibα mice had significantly lower platelet-monocyte associations relative to WT (P=0.003). This indicates a significant GP Ib-IX-dependent modulation of platelet binding to monocytes in the circulation. n=6 for each group. *P<0.05.
of CD41
+ events within the Gr-1 + /CD115 − gate was observed comparing WT and hIL-4R/Ibα samples (P=0.0008). Focusing on the monocyte population (Figure 2A and 2C) , a statistically significant reduction of CD41 + events within the CD115 + gate was also observed comparing WT and hIL-4R/Ibα samples (P=0.003), but no difference was observed between WT and VWF knockout samples (P=0.244). These preliminary findings demonstrate a reduction of CD41 + (platelet events) within neutrophil and monocyte populations in the hIL-4R/Ibα strain with no dependence on the presence or absence of VWF.
To further support the hIL-4R/Ibα findings, an alternative analysis was performed whereby CD41 + events were first identified in whole blood and then further gated for Gr-1 − population in WT samples, and this was reduced to 0.5% analyzing blood from the hIL-4R/Ibα strain. A similar reduction within the CD115 + population was also observed using hIL-4R/Ibα blood. No statistically significant difference was observed in comparing WT with VWF knockout samples. Thus, WT and VWF knockout blood contained a significantly higher percentage of the platelet population associated with neutrophils and monocytes when compared with hIL-4R/Ibα blood samples, further validating that platelet GP Ib-IX contributes to a platelet interaction with these leukocyte subclasses.
Platelet GP Ib-IX/Neutrophil and Monocyte Axes After CLP
The induction of severe sepsis significantly alters the ability to maintain homeostasis of both the inflammatory and hemostatic pathways. This global dysregulation of both physiological mechanisms could significantly alter the ability of platelets and leukocytes to interact because membrane receptor expression is rapidly modified via cellular activation events. To investigate the GP Ib-IX-dependent platelet-neutrophil/monocyte axis under septic-like conditions, we conducted the same flow cytometry analysis as described above with blood collected from WT and hIL-4R/Ibα mice 24 hours after CLP ( Figure 3A) . Overall, CD41
+ events within the Gr-1 + /CD115 − and CD115 + population for both WT and hIL-4R/Ibα blood samples were reduced after CLP compared with sham-treated controls ( Figure 3B and 3C) . hIL-4R/Ibα samples still displayed reduced platelet-neutrophil and platelet-monocyte interactions compared with WT samples after CLP, similar to that observed under normal conditions. In addition, we observed in both WT and hIL-4R/Ibα samples a positive shift in monocyte (CD115 + ) Gr-1 populations after CLP (comparing Figures 2 and 3) .
CLP-Induced Tumor Necrosis Factor-α Secretion
Platelets have been shown to be capable of influencing monocyte/macrophage secretion of tumor necrosis factor-α (TNF-α). 28 Having established that the loss of GP Ib-IX reduces the number of platelet-monocyte interactions, we further hypothesized that GP Ib-IX absence would cause an alteration in monocyte/macrophage secretion during sepsis. Before CLP, serum levels of TNF-α were undetectable in WT, hIL-4R/Ibα, or VWF knockout strains ( Figure 4A ). TNF-α was detectable at 4 and 12 hours after CLP with no difference between WT and hIL-4R/Ibα serums ( Figure 4A ). However, at 24 hours after CLP, TNF-α levels in hIL-4R/Ibα serum were, on average, significantly higher than serum levels from WT or VWF knockout mice ( Figure 4A and 4B) .
After observing the effect of GP Ib-IX on modifying TNF-α serum levels after CLP, we investigated potential GP Ib-IX influence on the secretion of other inflammatory mediators. Using a Multiplex platform, we found significant differences in several cytokines and chemokines 24 hours after CLP induction. A representative sampling revealed increase in hIL-4R/Ibα serum for monocyte chemotactic protein-1, IL-6, macrophage Figure 3 . Platelet-neutrophil and platelet-monocyte interactions after cecal ligation and puncture (CLP). A, Twenty-four hours after CLP, whole blood from wild-type (WT) and human interleukin-4 receptor (hIL-4R)/Ibα mice was analyzed via flow cytometry to determine glycoprotein Ib-IX (GP Ib-IX)-mediated platelet-neutrophil or platelet-monocyte events. B, The percentage of neutrophils bound by platelets is reduced after CLP in both animal strains relative to static conditions. C, A similar trend was observed in the monocyte gate with an overall reduction in platelet-associated events after CLP. Despite the overall reduction of platelet-associated events in both gates, WT samples did retain elevated interactions with platelets for both the neutrophil (P=0.04) and monocyte (P=0.05) populations. n=6 (normal); n=11 (24 hours after CLP). inflammatory protein-1β, and keratinocyte-derived chemokine while showing a reduction in IL-15 concentration ( Figure 5 ). Interestingly, these effectors are primarily secreted by the monocyte and macrophage population of cells. Cytokines associated with neutrophils did not reveal significant differences between WT and hIL-4R/Ibα samples (not shown). These findings provide evidence that the platelet modifies the secretion pattern of monocyte lineage cells in a GP Ib-IX-dependent manner.
Mac-1 Expression After CLP
Mac-1 is upregulated on the surface of neutrophils and monocytes during inflammation. Reserve pools are stored within vesicles that readily fuse with the plasma membrane on leukocyte activation. 29 After tethering and rolling on the inflamed endothelium, the leukocyte must firmly adhere to the vessel wall before initiating a slow crawl to endothelial junctions before extravasation occurs. [30] [31] [32] Thus, Mac-1 expression serves to indicate the migratory potential and activation state of the leukocyte.
Whole blood was collected as previously described and stained for neutrophils and monocytes. In addition, a marker for CD11b was added to identify Mac-1 (CD11b/CD18) expression. Under basal conditions, the Mac-1 expression by neutrophils did not differ between WT and hIL-4R/Ibα samples ( Figure 6A ). Furthermore, no significant difference was observed within the monocyte population ( Figure 6B ). Mac-1 expression was dramatically upregulated from basal conditions within the monocyte population for both WT and hIL-4R/Ibα samples collected 24 hours after CLP indicating that GP Ib-IX dysfunction did not directly lead to increased monocyte Mac-1 levels ( Figure 6B) . Interestingly, an increase in Mac-1 expression was observed in the hIL-4R/Ibα neutrophil population after CLP ( Figure 6A ). These results demonstrate that GP Ib-IX attenuates neutrophil Mac-1 expression during systemic inflammation.
Discussion
Platelets express receptors important in immunology, such as toll-like receptor 4, and this likely reflects the common origin for leukocytes and platelets, the thrombocyte, which functions in lower vertebrates in both hemostasis and inflammation. 10, 17, 33, 34 A common structural motif-the leucine-rich repeat-is present in each subunit of the GP Ib-IX complex and is a unifying motif for each of the 13 members of the toll-like receptor family. 35, 36 Thus, a participatory role for GP Ib-IX in both hemostasis and immune function could reflect an ancestral link between innate pattern recognition receptors and receptors dedicated to hemostasis. 17 More importantly, defining a GP Ib-IX-dependent role in immune regulation complements its well-characterized role in hemostasis and thrombosis and represents a significant advancement in defining the complex pathophysiologic response and sequelae of events associated with septic shock and death.
Although sepsis is primarily characterized as systemic inflammation, it is also a state of hemostatic dysregulation. 18 Indeed, the dysregulation of inflammation, coagulation, and the overlapping influence of each is a major challenge in accurately defining the septic syndrome. The platelet itself has been implicated as being an extension of the immune system because of its ability to elicit several inflammatory functions. 16, 33, 37 Platelet adhesion to leukocytes has been speculated to form an interface where cross-talk between the cellular mediators of inflammation and coagulation occurs. 38 The platelet's ability to bind neutrophils and monocytes, in particular, has been implicated as a critical factor in generating vascular inflammation. 39, 40 More challenging has been to define the importance of cellular activation at the level of the platelet, neutrophil, or monocyte for whether the interaction facilitates a proinflammatory or antiinflammatory state. Although under some conditions the platelet contributes to a proinflammatory state, our experiments identify a previously unidentified anti-inflammatory influence whereby an abrogated GP Ib-IX-dependent platelet interaction with monocytes results in elevated serum cytokine levels and increased Mac-1 expression by neutrophils. Twenty-four hours after CLP, the majority of monocyte-derived cytokines in the hIL-4R/Ibα mouse are significantly elevated ( Figure 5 ). This increase is reported from a single time point (24 hours) in a dynamic process. How this impacts the complex pathophysiology of sepsis and outcome is still unclear. However, the results are similar to a recent report of platelet depletion causing elevated serum levels of TNF-α and IL-6 in models of endotoxemia and Escherichia coli-induced sepsis. 41 Our initial findings that VWF knockout displayed improved survival after CLP suggested to us that if the platelet/VWF thrombotic axis was aiding the improved survival, mice deficient in GP Ib-IX would have a similar improved outcome. Because this was not the case (Figure 1 ), we sought to explore possible mechanisms where platelet GP Ib-IX might influence inflammation. We do acknowledge that the improved survival in VWF knockout mice could be unrelated to VWF's role in thrombosis and could reflect altered endothelial cell function, Weibel-Palade body formation, or even P-selectin expression. In fact, the concurrent dysregulated coagulation and inflammation of in vivo sepsis does complicate a simple explanation for why VWF knockout mice survive long and animals with dysfunctional GP Ib-IX die earlier. Despite an overwhelming inflammatory response in the hIL-4R/Ibα model, GP Ib-IX deficiency does drastically reduce the ability to generate occlusive thrombi. In contrast, WT mice have an intact GP Ib-IX complex participating in thrombosis, disseminated intravascular coagulation, and presumably organ failure during sepsis. Thus, although GP Ib-IX deficiency may protect against thrombosis, it subsequently contributes to excessive inflammation complicating the interpretation of survival as the single outcome.
Flow cytometry identified a GP Ib-IX-dependent interaction for platelets with neutrophils and monocytes under normal physiological conditions and after CLP. This interaction most likely reflects the known GP Ib-IX/Mac-1 axis. 25, 42 However, even in the absence of GP Ib-IX, there still exist platelet/neutrophil and platelet/monocyte populations. Although the GP Ib-IX relevance in platelet-neutrophil and platelet-monocyte interaction seems modest, the effects on cytokine release and Mac-1 expression 24 hours after CLP seem robust. The molecular basis of this interaction is unknown but could be dependent on the activation state of the platelet with exposure of potential counter-receptors, such as P-selectin. A caveat yet to be addressed in this analysis is whether the CD41 + population is composed of platelets or platelet-derived microparticles also linked to various aspects of platelet-mediated inflammation. 43 A variety of animal models have been developed to understand the molecular and genetic mechanisms of sepsis. 19, 44 The goal of each is to reproduce the pathophysiology observed in septic patients. The more simplistic approaches are the administration of exogenous toxins, such as lipopolysaccharide or viable pathogens. Both are relatively simple, reproducible, and restricted to toll-like receptor 4 pathways (lipopolysaccharide) or mechanisms of host response to pathogens. We have recently reported a prolonged survival after lipopolysaccharide administration in the absence of functional GP Ib-IX. 45 This improved outcome most likely reflects the predominant effects of thrombosis occurring in the lipopolysaccharide model and the importance of GP Ib-IX in pathological thrombus formation. The CLP model differs from lipopolysaccharide-induced endotoxemia by using the host's enteric bacteria to initiate the peritonitis followed by bacteria in the bloodstream, activation of an inflammatory response, and septic shock. 26 Furthermore, reports indicate variation in both thrombus formation and cytokine secretion when comparing lipopolysaccharide administration with CLP. 46, 47 Thus, major differences in key pathways exist when interpreting lipopolysaccharide experimental outcomes to CLP outcomes. 48 With respect to the GP Ib-IX/VWF axis, absence of ligand (VWF) is beneficial in CLP, whereas absence of the receptor (GP Ib-IX) is not. We conclude that platelet GP Ib-IX-dependent suppression of the inflammatory response is beneficial in CLP and less significant in the lipopolysaccharide model of endotoxemia.
Defining the importance of platelet GP Ib-IX to inflammation and thrombosis identifies opportunities to specifically target platelet function. Indeed, differentially targeting platelet function in inflammation and thrombosis to fit a specific pathophysiologic event or improve a clinical outcome would be a future goal. Recognizing an expanded functional influence for platelet GP Ib-IX in these processes is another piece to add to the complex pathophysiologic events of inflammation.
